Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It can also be announced earlier so it is not sure it will happen in february
They control it u cannot move such decision
Denner is behind this movement since years
He has been shorting this from 28 (old 2.8)
He needs all shares to cover the short end of the game
That s right
In fact they have 15 employees for doing what?
They are playing ping pong all day long i guess and the payslip at month end
They r following the instruction of fda b meeting so they are doing what has been required.
A b meeting normally means that there are no other issues otherwise they would have obtained only a c meeting.
Now the point u r mentioning is that the fda is suggesting something and then the fda suggests something else later on. With apricus everything is possible
Pascoe has the full interest in keeping a price up and avoid diluition
1) he has huge stock options
2) he will get 1.5 times his salary once the company will be sold out
3) it is a matter of reputation
4) he did it in somx
Casino u r trying again to support shorts...same story when u were mentioning he was sending curricula in ny
Pascoe is plenty of shares at 1.2
Not sure if he is interested to leave
Eicoman i lost the call can u pls summarize?
The equity is over 2.5 full stop
It is not sandoz debt
The ir told me is something else but did not specify the amount
Old
U maybe right
In fact we are borden line
Here the calculation
Apri got 11.5 mlns that impact the p&l
The 0.7 of inventory does nt touch the p&l
The 0.5 impact the p&l but only 250k i assume for q1
And then we have the big variable of the potential liabilities. We have 3.34 mlns (i need to check in the q10)
Now we had 7.6 mln equity neg in q3
We add 2.4 twice for q4 and q1
12.4 total loss
Plus 11.75 we go to minus 0.5
So everything depends on those other liabilities that they gave to ferring plus potential different results in q4 (i.e. Me may have received new milestones for the new devise)
So u do not know and i do not know
Now the surprises are not over so assuming they do not get the 2.5 mlns equity they can still pump the stock over 4.5 to get 35 mlns or even worst give also ryva away for few millions and we remain with vitaros us as unique asset.
We will know tomorrow toghether..
Now sorry i have other patients
Royalties in us seems to be in the higher range compared with ex-us
Also do not forget the basket loss apricus has that is valuable.
I think they achieved the 2.5 mlns equity and they will use aspire from october on.
At the end of the day they wonna last long now without anything left and i also doubt they will spend time and money on ryva as they do not seems to convinced about the asset. I would not surprised if they sell the entire asset soon and they prepare apricus for a buyout deal without any dust left.
That would be the right strategy to see back 15 usd
Allergan has to receive 1.5 mlns but also has to pay 25 mlns so i believe they offset each other.
Pascoe also said that apricus value would be min 150 mlns more with us approval.
Let s see
Short are acting
Something bad will happen
In the conf call next week they will announce that the meeting with fda went well and they go ahead with fda process
Waiting for monday
Casinokid u r patetic
Vitaros us value is above 100 mlns alone
Denner spoke with allergan and they will buy apricus for 200 mlns imo
They just cleaned up rest of world to make the transaction easier
Denner is behind
With this operation we will have kind of 7 mlns cash with a burn rate of 500k per month so we will go well till approval in us when we will get 25 mlns cash
I think they will also bring the capitalization above 35 to keep nasdaq requirment for the coming period
Today is the day
This cash allows the company to go to the fda approval
If they do not have further surprise from fda and as they stated they will fill the nda in july, then end of the game
Nda us is 150 mlns value deal and then they can sell
For sure they cleaned up the company for potential acquisition so if we get the approval allergan will buy us at 20 usd
The shorts have to cover now
They clearly bet on the delisting and now they are on trap, including casinokid
Still the big news to come is the status with the fda
If the meeting went in the right direction we will go over 5/6 by the next conf call when they will announce the next steps and the submission confirmation of vitaros us
We go over 2.5 mlns equity so we are ok for nasdaq
Ciao ciao short
Now u have to cover for the squeeze
We need to see if tomorrow with all the short we have we do not assist to an epic short squeeze
Would be sufficient
Ryva deal
Launch in europe by ferring
New devise meaning new milestone
New territories
Deal for femprox
Deal for fispemiphene
There are a lot of options we need to see if they use again the ass of shareholders to keep going
No
I checked also with ir
No aspire for the time being
Pascoe wrote to me that this time he will do his best to avoid cash raise as there are also limitation in doing so as within last year they raised more than 20% of the total shares.
As per my understanding they cannot do a secondary raise so they can do a private placement but i do not have clear in mind what s mean
I proposed to support the company with a consistent amount of money at 3 usd but he did not take me into consideration
I still believe they are doing a cash raise or convetible bond
In both case he will kill apricus if he do so
On the opposite he will be a great ceo if he find an agreement to pull some cash in
We will know it soon
Check better
Read twice bfr
There is a paraghraph where it is clearly stated it cannot be used
Aspire cannot be used.it is so clear in the 10q
They can restart using it from oct 2017 on.
Vitaros is a niche product with revenues that will easily go over 200 mlns with us approval...meaning 30/40 mlns per year of pure revenue as they do not manifacture anything do they just withdraw money.
Rights for 15 years so make ur assumptions.
Recordati launched in europe and ferring will follow...they believe in the product.
They have still valuable asset including ryva femprox and fispemifine.
If they deliver the room devise and they get fda approval there will be an enourmous potential here...20/30 usd easily....but now we have zero cash and we need to go over 4.5
I expect a cash raise imminent...that s why i sold half of my shares...but this company should be easily at 100 mlns cap today and for reason i cannot understand more than someone speculating with apricus we have a cap of 20 mlns.
Pascoe need to reduce costs further and find a buyer..
I am sure there are several company interested in taking money out from apricus
Bcz this company does not deserve any attention further.
I still old shares but i think it is a gamble as they tell us something and they keep doing something else!
It takes 60 days to get the fda meeting and still we are waiting news...he is keeping saying cash flow positive and then postpone it by another year
PASCOE is keeping saying that he will try to avoid cash raise and the short is raising drammatically meaning that they are preparring a massive cash raise...
I expect bad news on the qtr presentation and i wonna exit from this company asap...
I start doubting we will see 3 again.....sorry 0.3
How can a company reduce the value by 80% in one year and they are keeping receiving free shares bonuses and significant salaries...
This company needs to go private and cash out the investment
That s my view....i am really pissed off
Denner paid himself 20 mlns.
Do u believe he will sell his shares for 4 mlns?
I strongly believe in vitaros
I m afraid of what the management is doing as i really cannot explain why we are at a such low price and without visibility.
This meeting with fda is late and is impossible to get info about that.
Next conf call will bring bad news imo...
I sold half of my shares...plan to sell the other parts...there is absolutely no visibility at all here...good luck all exept the troll
The relaunch takes time as they have to get all the authorization back...means 6 months plus new mkting material...
Ryva is not an easy one but we may have a surprise...do not forget Denner is behind apricus and has much more power.
New territories are easy to partner....vitaros has been partnered all over the world..to sign a new agreement should be very simple...japan is also the second higher pe5 mkt
Also consider the new devise that will boost sales expecially in europe where people were unhappy with the old devise
The meeting with fda takes 60 days to be scheduled...i bet we will have the meeting bfr the q4 presentation.
Important to see if Pascoe is able to get cash in without diluition...this will be anyway the last one
To summarize potential news
Colombia or Russia turkey australia approval
Europe mexico canada launch
Meeting fda (not yet occurred)
Brazil japan partnership
Ryva exUs deal
Issue at this point is the shortage in cash as we are close to 0. They cannot use the cash machine so they have urgently to find a new source. Could be a loan but Pascoe would do a great work if they can cash out Ryva. Ferring would be a great partner for that. They have all the interest to finance apricus due to so many deals they have signed already
Probably the company is making cash with the cash machine
In the meantime i feel there is a new contract coming like ryva that will bring the equity up.
Alternatively they will drive the stock over 5 and make a capital raise
These days are fundamental but the sentiment on the stock is very positive as never in the last thee years
We are close to a big gap up in my opinion
Shares are few at this point
Let s see if denner will bring icahn here as he did with vivus
Casino how much have u been paid for trolling Apricus? Did the contract end?
Now u can restart with blow jobs
Apricus value is 250 mlns with fda approval.
If they will not buyout before this is the value .
With 200 mlns revenue per years mean that before 2032 they will generate revenue for 3 billions
Option for us for this famous raise of 15 mlns is to sell out ryva...make a new deal in us...raise cash over 6 usd...or just go over 35 mlns and get the easier compliance with nasdaq.
There are rumour of a buyout of allergan but i believe in ferring who will take the opt-in in us and will pay us at least 200 mlns easy
Aprivol what he said? Ant other news?
Casinokid see u at 5 usd
Denner is our miracle
Be ready tomorrow
As i am saying forendo is preparring the buyout of Apricus!
Probably in the last huge spike they bought a lot of shares!!
Time to flyyy
Mmmm....
1.3 mlns shares amd plus 5% in a friday without news seems a very good move.
I bet Pascoe has good news for next week to show in ny
Good news on fda?
Et voila!
Extension of nasdaq till may!
As casinokid predicted!
Now we need to go over 3.5 and raise 3 mlns shares to respect the 35 mlns role! Yeah